Clinical Trial Update: The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating interferon-gamma for sepsis-induced immunoparalysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Interferon-gamma (interferon gamma)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Sepsis, Septic Shock | Phase 3 | Status: COMPLETED